Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • MARTEK BIOSCIENCES CORP Financial Overview

  • Income Statement: MATK
      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 352.36 M 306.81 M 45.55 M 12.93%
    Gross Profit 138.09 M 106.94 M 31.16 M 22.56%
    Net Income Before Extra Items/Preferred Div 37.67 M 32.01 M 5.65 M 15.01%
    Operating Income 56.18 M 35.61 M 20.57 M 36.61%
    View Full Report

  • Cash Flow: MATK
      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing 1.10 M -33.74 M 34.84 M 3,156.25%
    Net Cash Flow - Investing 22.13 M 10.72 M 11.41 M 51.54%
    Net Cash Flow/Operating Activities 106.55 M 45.86 M 60.69 M 56.96%
    View Full Report

  • Balance Sheet: MATK

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 632.45 M 559.94 M 72.51 M 11.46%
    Total Liabilities 43.86 M 28.21 M 15.65 M 35.68%
    Shareholders Equity 588.58 M 531.73 M 56.86 M 9.66%
    View Full Report

  • Key Ratios / Statistics: MATK

    • Valuation

      Price/Earnings (TTM) 26.82
      Price/Sales (TTM) 2.86
      Price/Book (MRQ) 1.24
      Price/Cash Flow (TTM) 6.65

    • Profitability

      Gross Margin 39.19
      Operating Margin 15.94
      Profit Margin 10.69

    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00

    • Financial Strength

      Quick Ratio (MRQ) 3.02
      Current Ratio (MRQ) 7.10
      Long Term Debt-to-Equity (MRQ) 0.08

    • Management Effectiveness

      Return on Equity (TTM) 6.59
      Return on Assets (TTM) 6.27
      Return on Investments (TTM) 6.71
    View All Key Ratios